MAVYRET FDA approval date

The FDA approved MAVYRET on 3 Aug 2017.

FDA approval date
3 Aug 2017

Drug identity has not yet been verified against registry records

Also recorded as GLECAPREVIR; PIBRENTASVIR

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-08-03DayMAVYRETFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209394", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["MAVYRET"], "active_ingredients": ["GLECAPREVIR", "PIBRENTASVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170803", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026